SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001011060-09-000002
Filing Date
2009-03-04
Accepted
2009-03-04 17:17:37
Documents
3
Period of Report
2009-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 090302_ASB_CFO TERMINATION asbform8k090302.htm 8-K 33141
2 090302_ASB_CFO TERMINATION_EX 10.1 asbform8k090302_ex10-1.htm EX-10.1 42473
3 090302_ASB_CFO TERMINATION_EX 99.1 asbform8k090302_ex99-1.htm EX-99.1 8065
  Complete submission text file 0001011060-09-000002.txt   85513
Mailing Address 229 ANDOVER STREET WILMINGTON MA 01887
Business Address 229 ANDOVER STREET WILMINGTON MA 01887 978-657-0075
AdvanSource Biomaterials Corp (Filer) CIK: 0001011060 (see all company filings)

IRS No.: 043186647 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-11737 | Film No.: 09656361
SIC: 3841 Surgical & Medical Instruments & Apparatus